The pathobiology of pulmonary hypertension: Smooth muscle cells and ion channels

Clinics in Chest Medicine

Volumn 22, Issue 3, 2001, Pages 419-432

  Michelakis, Evangelos D ^a   Weir, E Kenneth ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ION; ION CHANNEL; POTASSIUM; POTASSIUM CHANNEL;

CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ARTERY; LUNG BLOOD VESSEL; LUNG CIRCULATION; LUNG VASOCONSTRICTION; MOLECULAR BIOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SMOOTH MUSCLE FIBER;

EID: 0034815008     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70281-1     Document Type: Article

References (53)

1. Appetite-suppressant drugs and the risk of primary pulmonary hypertension
2. Ion channels - Basic science and clinical disease
3. Source of nuclear calcium signals
4. Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension
5. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase
6. A redox-based oxygen sensor in rat pulmonary vasculature
7. Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia
8. Changes in glutathione status parallel changes in pulmonary vascular reactivity
9. 2-Sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase
10. + channels, Kv1.5 and Kv2. 1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes
11. 2-sensitive potassium channels in the pulmonary circulation
12. Isolation of two morphologically distinct cell lines from rat arterial smooth muscle expressing high tumorigenic potentials
13. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease
14. Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33
15. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo
16. 2 tension
17. 2+ transients in guinea-pig coronary myocytes. J Physiol (Lond)
18. 2+ channels in arterial smooth muscle cells
19. Pulmonary hypertension, "plexogenic pulmonary artericopathy" and the appetite-depressant drug aminorex: Post or propter
20. Pressure promotes DNA synthesis in rat cultured vascular smooth muscle cells
21. Intimalike smooth muscle cells: Developmental link between endothelium and media?
22. Effect of mechanical forces on growth and matrix protein synthesis in the in vitro pulmonary artery. Analysis of the role of individual cell types
23. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension
24. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine
25. Inhibition of hypoxic pulmonary vasoconstriction by calcium-channel antagonists in isolated rat lungs
26. Voltage-gated potassium channels in human ductus arteriosus
27. Potassium-channel diversity in vascular smooth muscle cells
28. Dexfenfluramine elevates systemic blood pressure by inhibiting potassium currents in vascular smooth muscle cells
29. Chloride-channel blockers inhibit myogenic tone in rat cerebral arteries
30. Physiological roles and properties of potassium channels in arterial smooth muscle
31. Different electrical responses to vasoactive agonists in morphologically distinct smooth muscle cell types
32. Selective loss of hypoxic pulmonary vasoconstriction in sSwap kv1.1/1.5 mice
33. + channel in pulmonary artery myocytes
34. Molecular biology of voltage-dependent potassium channels
35. 2+, independent of membrane potential
36. + channel activity and tone in rat vascular tissue
37. Inactivation properties of voltage-gated K channels altered by the presence of a β-subunit
38. Voltage-independent calcium entry in hypoxic pulmonary vasoconstriction of intrapulmonary arteries of the rat
39. Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension
40. Replication of smooth muscle cells in vascular disease
41. + current in rat pulmonary artery muscle cells
42. Dexamethasone rapidly induces Kv1.5 K + channel gene transcription and expression in clonal pituitary cells
43. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
44. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension
45. Vasoconstriction and media hypertrophy in pulmonary hypertension
46. + channels in human pulmonary artery smooth muscle cells
47. + channel α subunits in pulmonary artery smooth muscle cells
48. The mechanism of acute hypoxic pulmonary vasoconstriction: The tale of two channels
49. The anorexic agents, aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction
50. Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media
51. + currents regulate resting membrane potential and [Ca2 +]i in pulmonary artery myocytes
52. + channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension
53. + channel gene transcription in primary pulmonary hypertension